| For: | Darrat YH, Smer A, Elayi CS, Morales GX, Alqahtani F, Alkhouli M, Catanzaro J, Shah J, Salih M. Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis. World J Cardiol 2020; 12(7): 342-350 [PMID: 32843936 DOI: 10.4330/wjc.v12.i7.342] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v12/i7/342.htm |
| Number | Citing Articles |
| 1 |
Armando Tripodi, Vincenzo La Mura, Fabio Piscaglia, Bernardo Stefanini, Nicoletta Riva, Walter Ageno. Managing Coagulation Abnormalities, Bleeding, and Thrombosis in Patients with Cirrhosis. Journal of General Internal Medicine 2026; doi: 10.1007/s11606-026-10478-4
|
| 2 |
Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil. The prothrombotic tendency of metabolic-associated fatty liver disease. Journal of Thrombosis and Haemostasis 2023; 21(11): 3045 doi: 10.1016/j.jtha.2023.06.017
|
| 3 |
A.Y. Baylo, V.P. Shipulin, V.V. Cherniavskyi, L.M. Parunyan. 1. GASTROENTEROLOGY 2021; 55(1): 21 doi: 10.22141/2308-2097.55.1.2021.229432
|
| 4 |
A. G. Komarova, S. A. Bliznyuk, D. S. Lyasina, E. A. Naryshkina, A. V. Bumbu, S. D. Covantsev. Anticoagulant prophylaxis in patients with liver disease and atrial fibrillation. Medical alphabet 2024; (3): 17 doi: 10.33667/2078-5631-2024-3-17-22
|
| 5 |
Mehmet Baysal, Serap Baysal, Ecaterina Scarlatescu. Efficacy and safety of direct oral anticoagulants versus traditional anticoagulants in cirrhotic patients with venous thromboembolism and atrial fibrillation: a systematic review and meta-analysis. Scandinavian Journal of Gastroenterology 2026; : 1 doi: 10.1080/00365521.2026.2672441
|
| 6 |
Hongqun Liu, Sang-Youn Hwang, Samuel S. Lee. Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy. Pharmaceuticals 2023; 16(7): 978 doi: 10.3390/ph16070978
|
| 7 |
Iulia Cristina Marginean, Sergiu Marian Cazacu, Cristina Maria Marginean, Mihaela Popescu, George Alexandru Iacob, Marian Sorin Popescu, Cristin Constantin Vere. When Atrial Fibrillation Meets Alcoholic Liver Cirrhosis: Can Direct Oral Anticoagulants Bridge the Therapeutic Gap?. Biomedicines 2026; 14(3): 531 doi: 10.3390/biomedicines14030531
|
| 8 |
Adonis A. Protopapas, Christos Savopoulos, Lemonia Skoura, Ioannis Goulis. Anticoagulation in Patients with Liver Cirrhosis: Friend or Foe?. Digestive Diseases and Sciences 2023; 68(6): 2237 doi: 10.1007/s10620-023-07858-9
|
| 9 |
Sanjana Nagraj, Spyros Peppas, Maria Gabriela Rubianes Guerrero, Damianos G Kokkinidis, Felipe I Contreras-Yametti, Sandhya Murthy, Ulrich P Jorde. Cardiac risk stratification of the liver transplant candidate: A comprehensive review. World Journal of Transplantation 2022; 12(7): 142-156 doi: 10.5500/wjt.v12.i7.142
|
| 10 |
Erin M Hald, Katherine Wilkinson, Samuel A P Short, Suzanne E Judd, Virginia J Howard, Emily B Levitan, Elsayed Z Soliman, Mary Cushman. Circulating biomarkers and mortality in atrial fibrillation: the REasons for Geographic And Racial Differences in Stroke study. European Heart Journal Open 2026; 6(2) doi: 10.1093/ehjopen/oeag022
|
| 11 |
Asad Ali Ahmed Cheema, Muhammad Touseef, Maryam Asad, FNU Zeeshan, Ramesha Tahir, Bushra Areej, Mustafa Saad, Warda Nasir, Shayan Roshan, Fatima Hayat, Katee Kumari. Trends in atrial fibrillation/atrial flutter and cirrhosis-related mortality in the United States from 1999 to 2020: a CDC WONDER analysis. Annals of Medicine & Surgery 2026; doi: 10.1097/MS9.0000000000004940
|
| 12 |
Bert Vandenberk, Mario H. Altieri, Hongqun Liu, Satish R. Raj, Samuel S. Lee. Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension. Alimentary Pharmacology & Therapeutics 2023; 57(3): 290 doi: 10.1111/apt.17368
|
| 13 |
Xiya Lu, Zhijing Wang, Liu Yang, Changqing Yang, Meiyi Song. Risk Factors of Atrial Arrhythmia in Patients With Liver Cirrhosis: A Retrospective Study. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.704073
|
| 14 |
Irina Gîrleanu, Anca Trifan, Laura Huiban, Cristina Maria Muzica, Oana Cristina Petrea, Ana-Maria Sîngeap, Camelia Cojocariu, Stefan Chiriac, Tudor Cuciureanu, Remus Stafie, Sebastian Zenovia, Ermina Stratina, Adrian Rotaru, Robert Nastasa, Catalin Sfarti, Irina Iuliana Costache, Carol Stanciu. Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?. Diagnostics 2023; 13(6): 1160 doi: 10.3390/diagnostics13061160
|
| 15 |
Justin J. Song, Nicholas J. Jackson, Helen Shang, Henry M. Honda, Kristin Boulier. Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study. Journal of Cardiovascular Pharmacology and Therapeutics 2024; 29 doi: 10.1177/10742484241256271
|
| 16 |
Tae Hyung Kim, Seung Young Kim, Young Kul Jung, Hyung Joon Yim, Jin-Man Jung, Woo-Keun Seo. FIB-4 index and liver fibrosis are risk factors for long-term outcomes in atrial fibrillation-related stroke. Clinical Neurology and Neurosurgery 2022; 217: 107235 doi: 10.1016/j.clineuro.2022.107235
|
| 17 |
Sang Youn Hwang, Hongqun Liu, Samuel S. Lee. Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy. Biomedicines 2023; 11(7): 1895 doi: 10.3390/biomedicines11071895
|
| 18 |
Lavinia Alice Bălăceanu, Cristiana Grigore, Beatrice Bălăceanu-Gurău, Cristian-Dorin Gurău, Ioana Valeria Grigorescu, Ion Dina. Paroxysmal Atrial Fibrillation in Liver Diseases: Epidemiology and Possible Pathophysiological Mechanisms. Journal of Clinical Medicine 2026; 15(3): 1156 doi: 10.3390/jcm15031156
|
| 19 |
Nelson Barrera, Katerina Jou, Mushrin Malik, Francisco Gallegos‐Koyner, Salomon Chamay, Khaled Elfert, Roberto C. Cerrud‐Rodriguez, Luigi Di Biase. Safety of catheter ablation for atrial fibrillation in patients with liver cirrhosis. Journal of Cardiovascular Electrophysiology 2025; 36(1): 103 doi: 10.1111/jce.16472
|